|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.150 USD | -2.54% |
|
-17.86% | -81.21% |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 27.51M 24.19M 22.52M 20.68M 38.83M 2.64B 39.34M 268M 105M 1.3B 103M 101M 4.5B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 27.51M 24.19M 22.52M 20.68M 38.83M 2.64B 39.34M 268M 105M 1.3B 103M 101M 4.5B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.54% | ||
| 1 week | -17.86% | ||
| Current month | -24.84% | ||
| 1 month | -31.55% | ||
| 3 months | -59.65% | ||
| 6 months | -78.90% | ||
| Current year | -81.21% |
| 1 week | 1.11 |  | 1.41 |
| 1 month | 1.11 | | 1.95 |
| Current year | 1.11 | | 7.05 |
| 1 year | 1.11 | | 9.22 |
| 3 years | 1.11 | | 11.99 |
| 5 years | 1.11 | | 11.99 |
| 10 years | 1.11 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 2015-02-28 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 2024-01-31 |
Andrew Mazar
COO | Chief Operating Officer | 64 | 2022-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Thomson
BRD | Director/Board Member | 65 | 2022-08-31 |
Daniel Schmitt
BRD | Director/Board Member | 64 | 2015-03-31 |
Martin Huber
BRD | Director/Board Member | 66 | 2026-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/21/26 | Free | Director | 15,000 | 0.0633% | ||
| 5/21/26 | Free | Director | 15,000 | 0.0633% | ||
| 5/21/26 | Free | Director | 15,000 | 0.0633% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | -17.86% | -84.16% | - | 28.23M | |
| -1.82% | +4.80% | +56.71% | +68.36% | 57.28B | |
| -0.27% | +0.35% | +40.26% | +79.88% | 54.99B | |
| -2.05% | -2.14% | +0.75% | +413.38% | 23.18B | |
| +1.97% | -1.16% | -21.00% | -13.25% | 22.59B | |
| -0.72% | -1.18% | +19.88% | -11.41% | 20.46B | |
| +1.57% | +3.30% | +28.01% | -29.07% | 17.56B | |
| -1.85% | -1.47% | +31.94% | +544.91% | 15.67B | |
| +5.29% | +1.70% | +185.09% | +333.94% | 14.46B | |
| +0.79% | +0.50% | +22.39% | +184.74% | 13.92B | |
| Average | +0.03% | -0.43% | +27.98% | +174.61% | 24.01B | |
| Weighted average by Cap. | -0.22% | +1.53% | +39.10% | +136.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | US$1.150 | -2.54% | 226,822 |
| 26-07-24 | US$1.180 | -6.35% | 93,561 |
| 26-07-23 | US$1.260 | -0.40% | 118,313 |
| 26-07-22 | US$1.265 | -6.30% | 128,224 |
| 26-07-21 | US$1.350 | -3.57% | 114,704 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.150USD
Average target price
9.978USD
Spread / Average Target
+767.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
